期刊文献+

降钙素原在连续性血液净化治疗的脓毒症患者中的诊断意义

下载PDF
导出
摘要 目的:探讨PCT对Sepsis及SIRS的鉴别诊断意义及CBP对PCT的清除作用。方法:应用聚砜膜对我院ICU的Sepsis和SIRS患者行CBP治疗12 h,其中Sepsis组52例,SIRS组54例,于CBP开始前(0h)及CBP开始后2h、6 h、12 h,CBP结束后12 h测定患者血清PCT浓度。结果:血清PCT的初始浓度Sepsis组明显高于SIRS组,差异有显著性(P值<0.05)。血清PCT在CBP治疗后2 h,6 h,12 h均低于CBP前水平,与CBP前比较差异均无显著性(P值均>0.05)。结论:血清PCT可以作为非感染SIRS和感染脓毒症的重要鉴别诊断指标之一。
出处 《中国误诊学杂志》 CAS 2008年第6期1292-1293,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

  • 1吴丽娟,鲁涛,尹培刚,陈德生,陈福成.脓毒血症患者血浆降钙素原的变化及其意义[J].中日友好医院学报,2004,18(2):73-76. 被引量:31
  • 2Dahaba AA, Elawady GA, Rehak PH,et al. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients [J]. Anaesth Intensive Care, 2002,30 (3) :269-274,
  • 3Meisner M, Huttemann E, Lohs T,et al, Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients [J]. Shock, 2001,15 (3) : 171-175.

二级参考文献10

  • 1[2]Brunkhorst FM,Wegscheider K,Forychi ZF,et al.Procalcitonin for early diagnosis and differentiation of SIRS,sepsis,severe sepsis,and septic shock[J].Intensive Care Med,2000,26(Suppl 2):148-152.
  • 2[3]Eberhard OK,Langefeld I,Kuse ER,et al.Procalcitonin in the early phase after renal transplantation -will it add to diagnostic accuracy[J]? Clin Transplant,1998,12(3):206-211 .
  • 3[4]Brunkhorst FM,Eberhard OK,Brunkhorst R,et al.Discrimination of infectious and non-infectious causes of early acute respiratory distress syndrome by procalcitonin[J].Crit Care Med,1999,27(10):2172-2176.
  • 4[5]American College of Chest Phsicians/Society of Critical Care Medicine Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Crit Care Med,1992,20(6):864-874.
  • 5[6]Knaus WA,Draper EA,Wagner DP,et al.APACHEⅡ:A severity of disease classification system[J]. Crit Care Med,1985,13(10):818-829.
  • 6[7]Oberhoffer M,Ruwurm S,Bredle D,et al.Discriminative power of inflammatory markers for prediction of tumor necrosis factor-αand interleukin-6 in ICU patients with systemic inflammatory response syndrome(SIRS) or sepsis at arbitrary time points[J].Intensive Care Med,2000,26(Suppl 2):170-174.
  • 7[8]Meisner M,Tschaikowsky K,Palmaers T,et al.Procalcitonin and CRP inseptic shock:inflammatory parameters with different kinetics[J].Intensive Care Med,1996,22(Suppl 1):14.
  • 8[9]Reith HB,Mittelkotter U,Wagner R,et al.Procalcitonin(PCT) in patients with abdominal sepsis[J]. Intensive Care Med,2000,26(Suppl 2):165-169.
  • 9[10]Brunkhorst FK,Heinz U,Forycki ZF.Kinetics of procalcitonin in iatrogenic sepsis[J]. Intens Care Med,1998,24(8):888-892.
  • 10[1]Zeni F,Freeman BD,Natanson C,et al.Antiinflamatory therapies to treat sepsis and septic shock[J].Crit Care Med,1997,25(7):1095-1100.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部